Erasca (ERAS) Change in Accured Expenses (2020 - 2026)
Erasca (ERAS) posted Change in Accured Expenses of -$3.3 million for Q1 2026, down 295.75% on a QoQ basis from $1.7 million in Q4 2025, and up 59.17% year-over-year from -$2.1 million in Q1 2025.
Erasca (ERAS) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Erasca's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$3.3 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 59.17% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $969000.0 (down 51.93% YoY) and the FY2025 annual result came in at -$3.8 million, down 158.91% from the prior year.
- Change in Accured Expenses was -$3.3 million for Q1 2026 at Erasca, down from $1.7 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.5 million in Q3 2024 and bottomed at -$8.0 million in Q1 2025.
- A 5-year average of $122117.6 and a median of $1.3 million in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 1135.69% — and 2024, when it surged 240.13%.
- Erasca's Change in Accured Expenses stood at $2.1 million in 2022, then sank by 54.27% to $952000.0 in 2023, then jumped by 240.13% to $3.2 million in 2024, then slumped by 48.42% to $1.7 million in 2025, then plunged by 295.75% to -$3.3 million in 2026.
- Business Quant data shows ERAS's Change in Accured Expenses at -$3.3 million in Q1 2026, $1.7 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -16.74 Mn |
| 10 | Erasca | 5.84 Bn | 5.60 Bn | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.27 Mn |
| Mar 31, 2026 | -3.27 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | -8.01 Mn |
| Mar 31, 2025 | -8.01 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Dec 31, 2024 | 3.24 Mn |
| Sep 30, 2024 | 5.47 Mn |
| Sep 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | -3.63 Mn |
| Mar 31, 2024 | -3.63 Mn |
| Dec 31, 2023 | 952,000.00 |
| Dec 31, 2023 | 952,000.00 |